Vaccine News and Research

Latest Vaccine News and Research

Single dose of measles vaccine not sufficient to protect children against disease in Bangladesh

Research in Bangladesh has found that a quarter of children need more than single doses of the measles vaccine to be protected against the disease. This research supports the country's recent move to a double-dose approach.

6 Nov 2017

New study finds huge disparities in survival for patients with HPV-related cancers

A new study found large disparities by sex, race, and age in survival for patients diagnosed with different cancers caused by the human papillomavirus (HPV).

6 Nov 2017

Bulgaria reports outbreaks of bird flu (avian influenza)

Veterinary authorities in Bulgaria have called for culling of nearly 8,000 ducks according to a food safety agency yesterday after two more regions there have reported avian flu infection. According to the agency a total of four outbreaks of bird flu have been registered in Bulgaria at this time.

5 Nov 2017

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

3 Nov 2017

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models.

2 Nov 2017

World Hepatitis Summit 2017 calls for immediate action to tackle viral hepatitis

On the eve of the World Hepatitis Summit in Brazil, WHO reports increasing global momentum in the response to viral hepatitis. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016.

1 Nov 2017

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.

31 Oct 2017

Our chromosomes also wrinkle with age, research shows

Grey hair, wisdom, and wrinkles on our skin mark us as we age, but it's the more subtle changes beneath the surface that make us old. Now, researchers have discovered that our chromosomes also wrinkle with age, changing how our immune system renews itself.

31 Oct 2017

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Researchers caution against using antibodies to prevent HIV transmission from mother to child

HIV+ mothers who possess a strong neutralizing antibody response may be more likely to pass the virus on to her infant through breast feeding. In addition, infants born to mothers with a strong antibody response are significantly more likely to have a serious illness or death, regardless of whether or not they acquire the virus.

31 Oct 2017

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Stand Up To Cancer, joined by the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, announced today four teams of top researchers who will carry out an attack on cancers of the lung and pancreas using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated.

31 Oct 2017

Flu season: UAB experts recommend everyone to receive their yearly influenza vaccine

Flu season is here. The contagious respiratory illness caused by viruses that infect the nose, throat and lungs can cause mild to severe illness and at times may lead to death. People of every age - including people in good health - are at risk for flu.

28 Oct 2017

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.

28 Oct 2017

University of Colorado’s second shingles vaccine approved by FDA

The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.

28 Oct 2017

Report reveals 84% drop in global measles deaths, but disease still kills 90 000 every year

In 2016, an estimated 90 000 people died from measles - an 84% drop from more than 550 000 deaths in 2000 - according to a new report published today by leading health organizations. This marks the first time global measles deaths have fallen below 100 000 per year.

27 Oct 2017

Novel molecule holds potential to become part of successful HIV vaccine

Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.

27 Oct 2017

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

Today the Association of American Cancer Institutes, the American Cancer Society, Inc., and the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases announced 10 award winners as part of its HPV Vaccine Is Cancer Prevention campaign.

27 Oct 2017

International initiative led by Vanderbilt aims to develop universal flu vaccine

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

27 Oct 2017

Mumps outbreak in U.S. necessitates third booster dose of vaccine for at-risk individuals

According to a federal experts panel yesterday (25th October 2017), a third dose of mumps vaccine is recommended when there is an outbreak of the viral disease. There have been several mumps outbreaks since 2006 in the United States, especially among students who have already been vaccinated before. Last year 6366 cases of the highly infectious viral infection were reported in the United States.

27 Oct 2017

Dream Team plans to stop pancreatic cancer before symptoms occur

Deeply entrenched and mature by the time it's found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand Up to Cancer and led by an investigator at The University of Texas MD Anderson Cancer Center will test new ways to find the disease in its emerging, more vulnerable phase in people who are at high risk for developing it.

26 Oct 2017

Vaccine News and Research

Latest Vaccine News and Research

Single dose of measles vaccine not sufficient to protect children against disease in Bangladesh

New study finds huge disparities in survival for patients with HPV-related cancers

Bulgaria reports outbreaks of bird flu (avian influenza)

4-in-1 influenza vaccine appears to provide broad protection against flu

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

World Hepatitis Summit 2017 calls for immediate action to tackle viral hepatitis

Vedantra and Neon Therapeutics extend research alliance to develop impactful cancer therapies

Our chromosomes also wrinkle with age, research shows

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Researchers caution against using antibodies to prevent HIV transmission from mother to child

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Flu season: UAB experts recommend everyone to receive their yearly influenza vaccine

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

University of Colorado’s second shingles vaccine approved by FDA

Report reveals 84% drop in global measles deaths, but disease still kills 90 000 every year

Novel molecule holds potential to become part of successful HIV vaccine

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

International initiative led by Vanderbilt aims to develop universal flu vaccine

Mumps outbreak in U.S. necessitates third booster dose of vaccine for at-risk individuals

Dream Team plans to stop pancreatic cancer before symptoms occur

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in